Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01505101 · ClinicalTrials.gov registry record · Phase 1
Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy
A Phase 1 study of Chronic Pain and Opioid Abuse, Unspecified Use, sponsored by Florida State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 115
- Enrollment target
- 1
- Study location
NCT01505101 is a Phase 1 study of Chronic Pain and Opioid Abuse, Unspecified Use that has completed, run by Florida State University. The registered enrollment target is 115 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01505101, a Phase 1 study of Chronic Pain and Opioid Abuse, Unspecified Use, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 115 participants
- Enrollment target
- 1
- Study location
Study Summary
Persons suffering from chronic pain who are treated with long-term opioid therapy are at risk of misusing prescription opioids and developing opioid addiction. Moreover, long-term use of opioids may result in hyperalgesia, which exacerbates opioid craving and consumption. Mindfulness interventions have been shown reduce chronic pain symptoms, addictive processes, and substance use. The investigators hypothesize that relative to a support group control condition, participation in a novel mindfulness-oriented cognitive intervention, Mindfulness-Oriented Recovery Enhancement (MORE), will result in improved well-being and decreased pain, opioid craving, and opioid misuse behaviors among chronic pain patients receiving opioid therapy.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness-Oriented Recovery Enhancement
- BEHAVIORAL Conventional Support Group (SG)
Study Locations (1)
Florida
- FSU College of Social Work - Tallahassee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01505101
The ClinicalTrials.gov registry entry for NCT01505101 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (85% lower). The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness-Oriented Recovery Enhancement is the first listed.
NCT01505101 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01505101 about?
NCT01505101 is a clinical study titled "Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy". Persons suffering from chronic pain who are treated with long-term opioid therapy are at risk of misusing prescription opioids and developing opioid addiction. Moreover, long-term use of opioids may result in hyperalgesia, which exacerbates opioid craving and consumption. Mindfulness interventions h...
What is the current status of trial NCT01505101?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 115 participants. The study started on 2011-10. Estimated completion is 2013-07.
What conditions does trial NCT01505101 study?
This clinical trial studies the following conditions: Chronic Pain, Opioid Abuse, Unspecified Use.
What interventions are being tested in trial NCT01505101?
The interventions under investigation include: Mindfulness-Oriented Recovery Enhancement (BEHAVIORAL), Conventional Support Group (SG) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01505101?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01505101 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Managing Chronic Tendon Pain by Metformin
RECRUITING · Phase 1
-
Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling
RECRUITING · Phase 1
-
ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain
RECRUITING · Phase 1
-
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
RECRUITING · Phase 1
-
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
RECRUITING · Phase 1
-
Cognitive Behavioral Therapy for Insomnia in Chronic Pain Patients
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.